Conditions: Pulmonary Hypertension
Keywords: Sarcoidosis Associated Pulmonary Hypertension
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 12
Healthy volunteers: no

Brief summary:
This study is designed to assess safety and efficacy of tadalafil in patients with Sarcoidosis Associated Pulmonary Hypertension.

Hypothesis: Tadalafil is safe and effective in treating pulmonary hypertension in patients with Sarcoidosis

Detailed description:

Arms:
arm 1: Single-arm open-label proof of concept study of tadalafil in patients with sarcoidosis associated pulmonary hypertension.

Interventions: intervention 1: Tadalafil
Intervention descriptions: intervention 1: 20mg/day for one month then 40mg/day for additional 4 months

Protocol document: